Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticles for Inducing Antigen-Specific T Cell Tolerance in Autoimmune Diseases
Naomi Benne, Daniëlle ter Braake, Arie Jan Stoppelenburg, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25

Showing 25 citing articles:

Sequential immunotherapy: towards cures for autoimmunity
Francisco Ramírez‐Valle, Joseph Maranville, Sophie Roy, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 501-524
Closed Access | Times Cited: 6
Nanoparticle Adjuvants Incorporating Haptens Drive Potent Immune Tolerance to Accelerate Hair Regrowth
Ni An, Guzailinuer Yasen, Ximu Li, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Aerosol pulmonary immune engineering
Emma R. Sudduth, Michael Trautmann-Rodriguez, Nicole Gill, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114831-114831
Open Access | Times Cited: 17
Emerging strategies for nanomedicine in autoimmunity
Ajay S. Thatte, Margaret M. Billingsley, Drew Weissman, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115194-115194
Closed Access | Times Cited: 4
Autoantigenic Peptide and Immunomodulator Codelivery System for Rheumatoid Arthritis Treatment by Reestablishing Immune Tolerance
Yaping Mai, Xueting Yu, Ting Gao, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 4
Autoantigen‐Dexamethasone Conjugate‐Loaded Liposomes Halt Arthritis Development in Mice
Naomi Benne, Daniëlle ter Braake, Deja Porenta, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 3
Nanomaterials in Immunology: Bridging Innovative Approaches in Immune Modulation, Diagnostics, and Therapy
George-Alexandru Croitoru, Diana-Cristina Pîrvulescu, Adelina-Gabriela Niculescu, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 225-225
Open Access | Times Cited: 2
Epitope-based precision immunotherapy of Type 1 diabetes
Rebuma Firdessa Fite, Camillo Bechi Genzano, Roberto Mallone, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Antigen-specificity measurements are the key to understanding T cell responses
Rashmi Tippalagama, Leila Y. Chihab, Kendall Kearns, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves’ disease
Aakansha Zala, Ranjeny Thomas
Clinical & Experimental Immunology (2022) Vol. 211, Iss. 2, pp. 164-175
Open Access | Times Cited: 9
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Antigen-specific immunotherapies for autoimmune disease
Jane H. Buckner
Nature Reviews Rheumatology (2024)
Closed Access | Times Cited: 1
Tolerogenic Lipid Nanoparticles for Delivering Self-Antigen mRNA for the Treatment of Experimental Autoimmune Encephalomyelitis
Masaki Gomi, Yuka Nakayama, Yu Sakurai, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1270-1270
Open Access | Times Cited: 4
Reestablish immune tolerance in rheumatoid arthritis
Ziqiang Shuai, Shuang Zheng, Kang Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Recent Avenues in Treatment of Liver Diseases: Role of Nanotechnology
Manju Nagpal, Madhusmita Bhuyan, Malkiet Kaur, et al.
Current Drug Targets (2023) Vol. 24, Iss. 4, pp. 320-331
Closed Access | Times Cited: 2
Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis
Vivien Li, Michele D. Binder, Anthony W. Purcell, et al.
Journal of Neuroimmunology (2024) Vol. 390, pp. 578347-578347
Closed Access
Role of regulatory T cells in pathogenesis and therapeutics of spondyloarthritis
Miroslav Harjaček
Elsevier eBooks (2024), pp. 165-196
Closed Access
Enhanced Gut Microbiome Capacity for Amino Acid Metabolism is associated with Peanut Oral Immunotherapy Failure
Mustafa Özçam, Din L. Lin, Chhedi Lal Gupta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Strategies and delivery systems for cell-based therapy in autoimmunity
Matteo Puccetti, Claudio Costantini, Aurélie Schoubben, et al.
Frontiers in Drug Delivery (2024) Vol. 4
Open Access
New Developments and Challenges in Nanomaterial-Based Vaccine Delivery
Manish Kumar Panday, Manish Baboo Agarwal, Manu Mehrotra, et al.
Advances in chemical and materials engineering book series (2024), pp. 379-404
Closed Access
Lipid nanoparticle-based delivery of small interfering RNAs: New possibilities in the treatment of diverse diseases
Anis Askarizadeh, Fatemeh Vahdat‐Lasemi, Sercan Karav, et al.
European Polymer Journal (2024), pp. 113624-113624
Closed Access
Harnessing the biology of regulatory T cells to treat disease
Christine M. Wardell, Dominic A. Boardman, Megan K. Levings
Nature Reviews Drug Discovery (2024)
Closed Access
Mapping the tumor microenvironment in clear cell renal carcinoma by single-cell transcriptome analysis
Yu-Xiong Wang, Yishu Wang, Bin Liu, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
Synergistic targeting of immunologic pathways to empower durable tolerance therapies
Gerald T. Nepom
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 1
Lipid Nanoparticle-Mediated Delivery of CRISPR-Cas9 for Therapeutic Gene Correction
Johanna Walther
(2023)
Open Access
Page 1

Scroll to top